agnesium (Mg) deficiency is one of the most important triggers of coronary artery spasm in patients with vasospastic angina. 1-3 Some researchers have reported that patients with variant angina have a Mg deficiency and intravenous administration of Mg suppresses the anginal attacks. [4] [5] [6] Magnesium lowers systemic vascular resistance, dilates the coronary arteries, improves myocardial metabolism and stabilizes cell membranes. 7 Variant angina has been associated with the incidence of myocardial infarction (MI), 8 and in patients who have had an acute MI (AMI), Mg administration improves serious fatal arrhythmias and may thus decrease the mortality rate. 9 Coronary artery spasm is implicated in the genesis of acute coronary syndrome, but no data exist concerning the relationship between Mg deficiency and coronary artery spasm in patients with a recent AMI.
Japanese Circulation Journal Vol.65, July 2001 without coronary artery disease or provoked coronary vasospasm were matched for age and sex with the AMI patient group as control subjects. All 12 patients were studied because of chest pain or discomfort at rest and/or during exercise, and all 12 had less than 75% luminal narrowing and were diagnosed with atypical chest pain. The clinical data of the patients with AMI and control subjects are listed in Table 1 . For at least 1 month before the study, none of the patients had taken diuretics, digitalis, -blockers or other agents, such as gentamicin or carbenicillin, that would affect Mg metabolism.
Written informed consent was obtained from all patients before the study, and the protocol was in agreement with the guidelines of the institutional ethical committee.
Magnesium Loading Test
All the study participants were allowed to eat their regular diet during hospital stay. In the group with AMI, Mg loading tests were performed during both the acute (within 1 week (3±2 days) of the onset) and subacute phase (3-4 weeks (24±6 days) of the onset). All medications, including sublingual nitroglycerin, were continued during the Mg loading test. In the control group, the Mg loading tests were performed at least 1 week after admission. No conditions, including heart failure, intestinal malabsorption, loss of body fluids, liver cirrhosis, renal disease, or alcoholism (chronic excessive alcohol intake >81 g/day), that potentially lead to Mg depletion were found in any of the study subjects.
The Mg loading test was based on the method described by Ryzen et al. 10 Twenty-four-hour urine samples were collected to determine Mg excretion and creatinine clearance, after which subjects were given 0.1 mmol/kg bodyweight of Mg sulfate in 50 ml of 5% glucose intravenously over 4 h (between 06.00 h and 10.00 h). Blood samples were obtained for determination of serum Mg, calcium, and phosphorus before and immediately after completion of the Mg sulfate infusion. Twenty-four-hour urine samples, beginning with the infusion, were then collected to determine urine Mg. The serum and urine Mg concentrations were determined with an atomic absorption spectrophotometer, and the 24-h Mg retention (%) was calculated according to the formula: 24-h Mg retention (%) = (1 -(postinfusion urine Mgpreinfusion urine Mg) / total infusion of Mg) × 100
Spasm Provocation Test
Repeat coronary arteriography was performed from 10.00 h to 12.00 h using the Sones technique while patients were in the fasting state under no medication for 24 h, other than nitroglycerine during subacute phase. After baseline coronary arteriograms were obtained, an intracoronary injection of acetylcholine or ergonovine was performed: [11] [12] [13] [14] [15] acetylcholine was injected in incremental doses of 20, 50, and 80 g into the right coronary artery and 20, 50, and 100 g into the left coronary artery over 20 s, and ergonovine was administered in total doses of 40 g into the right coronary artery and 64 g into the left coronary artery over 4 min. A USCI bipolar electrode catheter was inserted into the right ventricular apex through the femoral or antecubital vein and was connected to a temporary pacemaker, setting the rate at 45 beats/min during acetylcholine testing. After the spasm provocation test was completed, intracoronary isosorbide dinitrate (5.0 mg) was administered, and coronary arteriography was again performed in multiple projections.
The coronary arteriograms were analyzed separately by 2 independent observers and their findings were classified according to the reporting system of the American Heart Association. 16 The percentage of luminal diameter narrowing of coronary arteries was measured by an automatic edge-contour detection computer analysis system (CARDIO 500, Kontron Instrument, Tokyo, Japan). The size of the coronary catheter was used to calibrate the image in millimeters and the measurement was performed in the same projection at each stage. Positive coronary spasm was defined as more than 90% transient luminal narrowing demonstrated angiographically in association with either anginal attacks or ischemic ST-segment deviation, or both. All data are shown as mean ± SEM. The statistical significance of differences between 2 groups was tested by Student's unpaired t test. One-way analysis of variance followed by Fisher's least significant difference test were performed to determine differences among 3 groups. A p value <0.05 was considered statistically significant.
Results

Clinical Characteristics, Serum Electrolyte, and 24-h Mg Retention Rate Between Patients and Controls
The prevalence of hypertension and a history of smoking in the AMI patients was significantly higher than in the control subjects, but the prevalence of hyperlipidemia and diabetes mellites did not differ between the 2 groups ( Table 1 ). The percentage of those receiving calcium-channel antagonists, isosorbide dinitrate and aspirin in the AMI patients with positive spasm was significantly higher than in those without provoked spasm. Serum calcium, phosphorus, and creatinine concentrations were within normal ranges for all the study subjects. As shown in Table 2 , there were no significant differences in baseline serum Mg concentration between the patient group with AMI and the control group (2.1±0.2 (acute), 2.2±0.2 (subacute) vs 2.1± 0.1 mg/dl, p=NS), but patients with AMI retained significantly more Mg than did control subjects (78±27 (acute), 66±32 (subacute) vs 48±12%, p<0.05) ( Table 3) .
Comparisons Between AMI Patients With and Without Provoked Spasm
Patients with AMI were further divided into 2 groups: 13 patients with provoked coronary artery spasm and 10 patients without spasm during the subacute phase. As shown in Table 4 , there was no significant difference in the peak value of creatine kinase (3,054±2,186 vs 2,830±1,874 IU/L, p=NS) or the left ventricular ejection fraction (54±12% vs 52±6%, p=NS) between the 2 groups. Nor was there a significant difference between the 2 groups regarding the other items. Patients with coronary vasospasm retained more Mg than those without spasm (84±25% and 43±26%, p<0.05) during the subacute phase, whereas in the acute phase no significant difference existed between the 2 groups (82±25% and 73±29%, NS; Fig 1) . However, there was no significant difference in the Mg retention of patients without coronary vasospasm in the subacute phase and that of control subjects. No difference in Mg levels existed between the 2 groups in both phases (Table 5) . Moreover, there was no significant difference in other electrolyte levels. Coronary spastic angina and old MI were each observed in 2 AMI patients with positive spasm, but only one of the AMI patients without a provoked spasm had a history of old MI. Of the 13 patients with a positive response, 12 (92%) had coronary artery spasm in the infarct-related artery. Spasm was provoked in 16 vessels: 12 in the infarct-related artery and 4 in non-infarct-related vessels. Post infarction angina was determined in 7 (54%) of the 13 AMI patients with a positive spasm reaction, whereas only 1 patient (10%) had an angina attack after AMI in the 10 patients without a provoked spasm (Table 4) . No significant difference in the 24-h Mg retention rate existed between patients with (acute: 83±25%, subacute: 77±31%) or without (75± 28, 60±32%) post infarction angina attacks. Table 6 shows that there was no difference in the 24-h Mg retention rates of the 3 groups, and, moreover, the electrolyte levels measured during both phases did not differ among the groups.
Comparison Among Acute Therapy
Comparison Between AMI Patients With and Without Organic Stenosis in the Subacute Phase
There was no difference in the 24-h Mg retention rate and the serum electrolyte levels between patients with and without organic stenosis in both phases (Table 6 ).
Discussion
The Mg loading test revealed that high levels of Mg retention existed in patients with AMI in both the acute and subacute phase, and furthermore, the 24-h retention of Mg was much greater in those with a provoked coronary vasospasm in the subacute phase. There was no significant difference in the 24- 
24-h Mg retention rate (%)
PTCA, percutaneous transluminal coronary angioplasty. Twenty-four-hour Mg retention (%) in AMI patients with and without spasm. There is no difference in the 24-h Mg retention rate between the acute and subacute phases in AMI patients with a positive spasm response (n=13), whereas in AMI patients without a provoked spasm (n=10) the 24-h Mg retention rate during the subacute phase is significantly decreased compared with during the acute phase.
subacute phase and control subjects. These findings suggest that Mg deficiency may play a role in the occurrence of AMI by means of coronary artery spasm.
Mg Deficiency and Coronary Vasospasm
Goto et al reported Mg deficiency in patients with variant angina 1 and recently, Satake et al reported that the 24-h Mg retention rate and intracellular concentrations of Mg in mononuclear cells and erythrocytes correlated well with the frequency of anginal attacks in patients with variant angina. A previous study revealed that Mg deficiency was one of the cause of coronary artery spasm, and clinical studies have also demonstrated that intravenous administration of Mg to patients with variant angina suppresses hyperventilation-induced anginal attacks, 4 exercise-induced angina, 5 and, in part, accelerated exercise following mild hyperventilation-induced angina 6 with ST-segment elevation. Mg deficiency has been detected in patients with AMI, as well as in those with coronary spastic angina. However, it is unknown whether the mechanism of the deficiency in patients with AMI is similar to that in patients with coronary spastic angina. Most likely, the pathogenesis of coronary spasm is multifactorial.
AMI and Coronary Vasospasm
Coronary vasospasm is one of the most important triggers of acute coronary syndrome and according to previous reports, 18, 19 the frequency of provoked coronary artery spasm in patients with AMI is significantly higher than in controls. Thus, patients with AMI had higher coronary vasoactivity. Moreover, the incidence of coronary artery spasm provoked with intracoronary acetylcholine is 2-3 times higher in Japanese patients with a recent MI than in Caucasian patients. In the present study, coronary spasm was observed in 57% (13/23) of patients with a recent AMI, which is a similar frequency of coronary spasm to that reported in other studies (69-80%). [18] [19] [20] 
AMI and Mg Deficiency
It has been reported that patients with AMI have a transient hypomagnesemia and an intravenous Mg-loading test revealed a Mg deficiency compared with control subjects. [21] [22] [23] Elevated levels of catecholamines and the subsequent changes in the renal handling of Mg could lead to Mg deficiency in patients with AMI, as well as in those with chronic heart failure associated with high levels of norepinephrine. 21, 23 Mg deficiency was found in the present patients with AMI in both the acute and subacute phases. Elevated catecholamines may be one of the causes of Mg deficiency in the acute phase, but for the subacute phase, the mechanism of Mg deficiency is controversial. Although a causal relation between Mg deficiency, coronary artery spasm and AMI remains to be elucidated, our study clearly demonstrated that coronary spasm was provoked in association with Mg deficiency in patients with a recent MI.
Clinical Implications
Mg deficiency may play a role in the induction of coronary vasospasm during the acute phase in some patients with AMI. Therefore, it is beneficial to administer Mg to reduce coronary vasoactivity in the acute phase. In previous large studies of Caucasian patients, [23] [24] [25] there was no clinical evidence for the routine use of Mg for patients with AMI, but intravenous administration of Mg may have a different result in Japanese patients with AMI because of their greater incidence of coronary artery spasm. 26 Some conclusions can be drawn from the results of the present study. First, -blocker should be administered prudently in recent AMI patients with spasms provoked during the acute and subacute phase, because -blockers may aggravate coronary arterial spasm. Second, not only aspirin but also per os or intravenous Mg may be helpful in some oriental patients experiencing an AMI.
The prognosis did not differ between the 2 groups during the hospital stay. Moreover, the prevalence of post infarction angina, a history of old MI, or a history of coronary spastic angina did not differ in the AMI patients with and without a provoked spasm. In AMI patients with a positive spasm response during the acute and subacute phases, not only calcium-channel blockers but also intravenous or per os Mg may be effective in reducing coronary vasoactivity.
Study Limitations
This study has 4 limitations. First, we did not measure the concentration of serum cathecolamines in the acute and subacute phases. We excluded patients with heart failure or those requiring catecholamine administration as part of their therapy. All patients had an AMI classified into Killip I. Second, we ignored the dietary intake of Mg and the administration of calcium antagonists. Alcohol intake and smoking were discontinued during the hospital stay and did not occur during the Mg loading test. Third, the study included a small number of patients, and fourth, we did not measure the intracellular Mg concentration. Only 1% of the total body Mg exists in the extracellular space.
In conclusion, there may be a close association between Mg deficiency and provoked coronary artery spasm in half of the Japanese patients with recent AMI during the subacute phase. Further studies are needed to clarify the correlation between Mg deficiency and coronary spasm.
